Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 28, 2017; 23(20): 3713-3720
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3713
Figure 1
Figure 1 Serum miRNA-106b levels of patients that underwent health checkups.
Figure 2
Figure 2 Results of qPCR.
Figure 3
Figure 3 Early hepatocellular carcinoma B-ultrasound results.
Figure 4
Figure 4 Difference in miRNA-106b expression levels between the two groups were statistically significant (aP < 0. 001).
Figure 5
Figure 5 Receiver operating characteristic curve analysis of the differences in miRNA-106b expression.